Codiak Biosciences Inc

NASDAQ:CDAK   3:59:52 PM EDT
2.33
-0.06 (-2.51%)
Earnings Announcements

Codiak Biosciences Reports Second Quarter 2022 Financial Results And Operational Progress

Published: 08/04/2022 20:58 GMT
Codiak Biosciences Inc (CDAK) - Codiak Biosciences Reports Second Quarter 2022 Financial Results and Operational Progress.
Codiak Biosciences, Inc. - Q2 Total Revenues $13.1 Million, Compared to $0.9 Million.
Revenue is expected to be $0.59 Million
Adjusted EPS is expected to be -$0.77

Next Quarter Revenue Guidance is expected to be $0.59 Million
Next Quarter EPS Guidance is expected to be -$0.54

More details on our Analysts Page.